BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30022146)

  • 1. Renoprotective effects of a factor Xa inhibitor: fusion of basic research and a database analysis.
    Horinouchi Y; Ikeda Y; Fukushima K; Imanishi M; Hamano H; Izawa-Ishizawa Y; Zamami Y; Takechi K; Miyamoto L; Fujino H; Ishizawa K; Tsuchiya K; Tamaki T
    Sci Rep; 2018 Jul; 8(1):10858. PubMed ID: 30022146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation Factor Xa and Protease-Activated Receptor 2 as Novel Therapeutic Targets for Diabetic Nephropathy.
    Oe Y; Hayashi S; Fushima T; Sato E; Kisu K; Sato H; Ito S; Takahashi N
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1525-33. PubMed ID: 27283743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction.
    Nagatoya K; Moriyama T; Kawada N; Takeji M; Oseto S; Murozono T; Ando A; Imai E; Hori M
    Kidney Int; 2002 May; 61(5):1684-95. PubMed ID: 11967018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral ureteral obstructive nephropathy.
    Omori H; Kawada N; Inoue K; Ueda Y; Yamamoto R; Matsui I; Kaimori J; Takabatake Y; Moriyama T; Isaka Y; Rakugi H
    Clin Exp Nephrol; 2012 Aug; 16(4):549-56. PubMed ID: 22350467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow-derived mesenchymal stem cells attenuate tubulointerstitial injury through multiple mechanisms in UUO model.
    Xing L; Song E; Yu CY; Jia XB; Ma J; Sui MS; Wang MA; Gao X
    J Cell Biochem; 2019 Jun; 120(6):9737-9746. PubMed ID: 30525227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Danggui Buxue Tang Attenuates Tubulointerstitial Fibrosis via Suppressing NLRP3 Inflammasome in a Rat Model of Unilateral Ureteral Obstruction.
    Wang L; Ma J; Guo C; Chen C; Yin Z; Zhang X; Chen X
    Biomed Res Int; 2016; 2016():9368483. PubMed ID: 27872860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mizoribine improves renal tubulointerstitial fibrosis in unilateral ureteral obstruction (UUO)-treated rat by inhibiting the infiltration of macrophages and the expression of alpha-smooth muscle actin.
    Sakai T; Kawamura T; Shirasawa T
    J Urol; 1997 Dec; 158(6):2316-22. PubMed ID: 9366383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SREBP inhibition ameliorates renal injury after unilateral ureteral obstruction.
    Mustafa M; Wang TN; Chen X; Gao B; Krepinsky JC
    Am J Physiol Renal Physiol; 2016 Sep; 311(3):F614-25. PubMed ID: 27385736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy.
    Ishidoya S; Morrissey J; McCracken R; Klahr S
    Kidney Int; 1996 Apr; 49(4):1110-9. PubMed ID: 8691732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mizoribine ameliorates the tubulointerstitial fibrosis of obstructive nephropathy.
    Sato N; Shiraiwa K; Kai K; Watanabe A; Ogawa S; Kobayashi Y; Yamagishi-Imai H; Utsunomiya Y; Mitarai T
    Nephron; 2001 Oct; 89(2):177-85. PubMed ID: 11549900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Edoxaban Exerts Antioxidant Effects Through FXa Inhibition and Direct Radical-Scavenging Activity.
    Narita Y; Hamamura K; Kashiyama M; Utsumi S; Kakizoe Y; Kondo Y; Ishitsuka Y; Jono H; Irie T; Mukoyama M; Saito H; Kadowaki D; Hirata S; Kitamura K
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of a combination of Rho-kinase inhibitor and ACE inhibitor on tubulointerstitial fibrosis induced by unilateral ureteral obstruction.
    Takeda Y; Nishikimi T; Akimoto K; Matsuoka H; Ishimitsu T
    Hypertens Res; 2010 Sep; 33(9):965-73. PubMed ID: 20664550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cyclooxygenase-2 in the development of interstitial fibrosis in kidneys following unilateral ureteral obstruction in mice.
    Kamata M; Hosono K; Fujita T; Kamata K; Majima M
    Biomed Pharmacother; 2015 Mar; 70():174-80. PubMed ID: 25776498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor Xa inhibitor, edoxaban ameliorates renal injury after subtotal nephrectomy by reducing epithelial-mesenchymal transition and inflammatory response.
    Fang L; Ohashi K; Ogawa H; Otaka N; Kawanishi H; Takikawa T; Ozaki Y; Takahara K; Tatsumi M; Takefuji M; Murohara T; Ouchi N
    Physiol Rep; 2022 Mar; 10(5):e15218. PubMed ID: 35262272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semicarbazide-sensitive amine oxidase (SSAO) inhibition ameliorates kidney fibrosis in a unilateral ureteral obstruction murine model.
    Wong M; Saad S; Zhang J; Gross S; Jarolimek W; Schilter H; Chen JA; Gill AJ; Pollock CA; Wong MG
    Am J Physiol Renal Physiol; 2014 Oct; 307(8):F908-16. PubMed ID: 25143459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstruction.
    Baba I; Egi Y; Utsumi H; Kakimoto T; Suzuki K
    Mol Med Rep; 2015 Dec; 12(6):8010-20. PubMed ID: 26498136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/Smad signaling pathway.
    Kim D; Lee AS; Jung YJ; Yang KH; Lee S; Park SK; Kim W; Kang KP
    Nephrol Dial Transplant; 2014 Nov; 29(11):2043-53. PubMed ID: 25031017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of Tubular Injury and Renal Fibrosis by TI-HU-YIN via Reduction in Transforming Growth Factor-β1 Expression in Unilateral Ureteral Obstruction Mice.
    Tarng DC; Liu IS; Lin LC; Chen NJ
    Chin J Physiol; 2015 Dec; 58(6):367-76. PubMed ID: 26717915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The selective A3AR antagonist LJ-1888 ameliorates UUO-induced tubulointerstitial fibrosis.
    Lee J; Hwang I; Lee JH; Lee HW; Jeong LS; Ha H
    Am J Pathol; 2013 Nov; 183(5):1488-1497. PubMed ID: 24001475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Edoxaban, a direct factor Xa inhibitor, suppresses tissue-factor induced human platelet aggregation and clot-bound factor Xa in vitro: Comparison with an antithrombin-dependent factor Xa inhibitor, fondaparinux.
    Honda Y; Kamisato C; Morishima Y
    Thromb Res; 2016 May; 141():17-21. PubMed ID: 26962981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.